Drug Shortage Report for OXERVATE
| Report ID | 201866 |
| Drug Identification Number | 02485613 |
| Brand name | OXERVATE |
| Common or Proper name | CENEGERMIN |
| Company Name | DOMPÉ FARMACEUTICI S.P.A. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | |
| Strength(s) | 0.002% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 7 X 1 ML OXERVATE MULTIDOSE GLASS VIALS |
| ATC code | S01XA |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-08-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | 2024-07-17 |
| Shortage status | Resolved |
| Updated date | 2024-08-08 |
| Company comments | SUPPLY OF CANADIAN LABELLED OXERVATE IS BEING DEPLETED/NEAR EXPIRY AND CANNOT BE REPLENISHED DUE TO LIMITED DEMAND AND SUPPLY CHALLENGES. |
| Health Canada comments | A discontinuation report will be submitted. Expiry date of the last lot 21L7641 sold on the Canadian market was June 22, 2024. An official notification was submitted to Health Canada on July 31st. |
| Tier 3 Status | No |
| Contact Address | VIA SANTA LUCIA, 6 MILANO, MILAN ITALY 20122 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-08-08 | French | Compare |
| v5 | 2024-08-08 | English | Compare |
| v4 | 2023-08-31 | English | Compare |
| v3 | 2023-08-15 | French | Compare |
| v2 | 2023-08-15 | English | Compare |
| v1 | 2023-08-15 | English | Compare |
Showing 1 to 6 of 6